An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world.
Jan 17, 2022
0
275
The time between diagnosis and the institution of symptomatic treatment is critical in the effort to find a cure for Parkinson's Disease (PD). A paper published in Nature Partner Journal: Parkinson's Disease notes too many ...
Sep 27, 2018
0
50
The dementia disorder Alzheimer's disease has a symptom-free course of 15 to 20 years before the first clinical symptoms emerge. Using an immuno-infrared sensor developed in Bochum, a research team is able to identify signs ...
Jul 21, 2022
0
91
Neuroscientist Tony Wyss-Coray, Ph.D., has spent 20 years unearthing and examining various molecules with neuroprotective and neurodegenerative properties. These molecules are found in or on different cell types in the brain ...
Aug 2, 2022
0
7
Professor Valter Longo, director of the USC Longevity Institute, is investigating how fasting and diets that mimic fasting's effects can help immune function, including vaccine efficacy and the body's response to infection ...
Apr 27, 2020
0
2
Scientists have developed a pioneering new technique that can detect and diagnose one of the most common types of cancer within seconds—using light.
Nov 11, 2019
0
1
Ovarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured, and approximately 12,810 people in the U.S. die from the disease every year.
Apr 26, 2022
0
2
Hepatitis B is blood-borne virus that packs a punch. Worldwide, more than 1.3 billion people have been infected with hepatitis B, and 257 million people have developed a life-long infection. This includes 240,000 Australians, ...
Oct 24, 2019
0
2
Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, were able to identify a new approach for the therapy of colorectal cancer (CRC) as part of an interdisciplinary project of the LOEWE Center Frankfurt Cancer ...
Oct 20, 2022
0
158
Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet ...
Jan 23, 2024
0
89
